These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19563378)

  • 1. Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right?
    Zidehsarai MP; Moe SM
    Nephrology (Carlton); 2009 Jun; 14(4):374-82. PubMed ID: 19563378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for reliable serum parathyroid hormone measurements.
    Torres PU
    Kidney Int; 2006 Jul; 70(2):240-3. PubMed ID: 16838038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach for evaluating bone turnover in chronic kidney disease.
    Tolouian R; Hernandez GT; Chiang WY; Gupta A
    Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment.
    White CA; Sarabia S; Collier CP; McCudden C; Holden RM
    Clin Biochem; 2021 Aug; 94():62-66. PubMed ID: 33895125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on vitamin D therapy in chronic kidney disease.
    Tentori F
    J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134
    [No Abstract]   [Full Text] [Related]  

  • 6. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC; Boutten A; Carlier MC; Chevenne D; Coumaros G; Lawson-Body E; Massart C; Monge M; Myara J; Parent X; Plouvier E; Houillier P
    Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease.
    Bencova V; Maris K; Spustova V; Gazovic V; Straussova Z; Cernohorska B; Nemethova D
    Bratisl Lek Listy; 2014; 115(7):439-41. PubMed ID: 25077368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of assays for parathyroid hormone.
    Goodman WG
    Semin Dial; 2005; 18(4):296-301. PubMed ID: 16076352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T; Ishida M; Fukagawa M
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
    Sankarasubbaiyan S; Abraham G; Soundararajan P; Chandrasekaran V; Padma G
    Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T; Sci B
    Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone biopsy in chronic kidney disease: still an option?
    Drueke TB
    J Bras Nefrol; 2020 May; 42(2):130-132. PubMed ID: 32459283
    [No Abstract]   [Full Text] [Related]  

  • 14. Pth 1-84, Pth fragments and bone turnover.
    Malluche HH; Monier-Faugere MC
    Am J Kidney Dis; 2003 May; 41(5):1127. PubMed ID: 12722056
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
    Gao P; D'Amour P
    Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expectation for Whole PTH assay in the dialysis field].
    Tokumoto A
    Clin Calcium; 2005 Feb; 15(2):273-80. PubMed ID: 15692169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
    Goodman WG
    Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical considerations in PTH testing.
    Souberbielle JC; Friedlander G; Cormier C
    Clin Chim Acta; 2006 Apr; 366(1-2):81-9. PubMed ID: 16310759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary.
    Cantor T
    Clin Chem; 2009 Sep; 55(9):1740. PubMed ID: 19717661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.